Loading company…
ProX MS develops and manufactures UPLC and tandem mass spectrometry systems for clinical use.
ProX MS develops and produces UPLC and tandem mass spectrometry systems, including the NGM, C45, C65 and SCT clinical devices. Founded in 2020, the company is based in Ningbo, China. In February 2026, it raised Series A funding from Bison Capital, Ningbo Science and Technology Financial Service Center and MF Capital to advance research, expand production and pursue registrations.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in